Chief Executive Officer | Philadelphia College of Osteopathic Medicine
Skip to main content

JAY S. FELDSTEIN, DO '81
President and Chief Executive Officer

215-871-6800

Jay S. Feldstein, DO '81, serves as the eighth president and chief executive officer of Philadelphia College of Osteopathic Medicine. In this role, Dr. Feldstein, in conjunction with the PCOM Board of Trustees, supervises and controls all of the business and affairs of the institution including oversight of the Primary Care Innovation Fund.

Dr. Feldstein holds an impressive record of success in healthcare management. From 2010-2014, he served as president, Northern Division, Pennsylvania Managed Care Plans, at AmeriHealth Caritas Family of Companies.

He has worked as corporate chief medical officer/senior vice president and chief medical officer/senior vice president, Medical Affairs at AmeriHealth Caritas; as senior medical director, Mid-Atlantic region, and director, Network Medical, Southern New Jersey/Delaware division at Aetna; as medical director at Concentra Health Center; as president/chief executive officer at Occupational Health Resources, Inc.; as founder, president and medical director at Spectracare Occupational Health Services; and as a physician and board member at Doctors for Emergency Services.

Philadelphia Business Journal Most Admired CEO Awards Logo featuring Jay S. Feldstein, DOIn 2019, Dr. Feldstein was invited to join Philadelphia Business Journal Leadership Trust, an exclusive community for influential business leaders, executives and entrepreneurs in Greater Philadelphia. He serves on the Board of Directors for MANNA and the Hospital and Healthsystem Association of Pennsylvania, and he was appointed by Pennsylvania Governor Josh Shapiro and Lieutenant Governor Austin Davis to serve on the incoming administration’s Transition Advisory Committee on Health and Human Services.

In 2021, Dr. Feldstein was honored with the American Osteopathic Association's inaugural Diversity, Equity, and Inclusion (DEI) Unification Award for his exemplary leadership and commitment to promoting and advancing DEI at PCOM and in the osteopathic medical profession. And in 2023, Dr. Feldstein was named one of Philadelphia Business Journal's Most Admired CEOs.

Dr. Feldstein has written for Fortune, U.S. News & World Report, Modern Healthcare, Newsweek, and the Philadelphia Business Journal, among others.

Dr. Feldstein earned his bachelor's degree from Penn State University and his Doctor of Osteopathic Medicine degree from PCOM. He completed his residency in emergency medicine at the Medical Center of Delaware and his internship at John F. Kennedy Memorial Hospital in Stratford, New Jersey. He is board certified in occupational medicine and is a fellow of the American College of Preventive Medicine.

OFFICE OF THE PRESIDENT

Education

  • Bachelor's degree - Penn State University
  • Doctor of Osteopathic Medicine - Philadelphia College of Osteopathic Medicine

Awards

  • Philadelphia Business Journal's Most Admired CEOs Award, 2023
  • American Osteopathic Association's Diversity, Equity and Inclusion Unification Award, 2021
  • Inducted into Northeast High School's Wall of Fame, 2018
  • CEO Leadership Award presented by the Pennsylvania Diversity Council, 2014

Media

April 2024

Commentary, Newsweek, "I'm a Doctor on Ozempic—It's Effective Under One Condition"

February 2024

Commentary co-authored with U.S. Rep Brian Fitzpatrick, Modern Healthcare, "Opinion: Fix the residency bottleneck shortage"

December 2023

Featured, Philadelphia Business Journal, 2023 Most Admired CEO Awards

November 2023

Commentary, Philadelphia Business Journal Leadership Trust, "Persistence and perseverance: Leadership from a first-generation perspective"

Featured, City & State PA, The 2023 Fifty Over 50

October 2023

Featured, Philadelphia Business Journal, 2023 Most Admired CEO Awards

Featured, Metro Philadelphia, Health Care Power Players 2023

August 2023

Commentary, U.S. News & World Report"Why America Needs More Diversity in the Doctor's Office"

June 2023

Commentary, Fortune, "Persistent health disparities are proof that DEI programs remain necessary–even as the term becomes a political football"

March 2023

Featured, City & State PA, "The 2023 Health Care Power 100"

February 2023

Featured, City & State PA, "The 2023 Higher Education Power 100"

January 2023

Q&A with Philadelphia Business Journal 

X